Reuters US Business

Factbox-Major corporations shift listings to Nasdaq amid growing tech focus

(Reuters) -Walmart said on Thursday it would move its longtime listing on the New York Stock Exchange to Nasdaq, joining the tech-heavy exchange as one of its most valuable members. The shift, scheduled for December 9, underscores the retail giant’s push to become more technology-focused — from integrating artificial intelligence across operations to accelerating e-commerce …

Factbox-Major corporations shift listings to Nasdaq amid growing tech focus Read More »

Waymo to broaden US robotaxi footprint with moves into Minneapolis, Tampa, New Orleans

(Reuters) -Alphabet’s Waymo will expand its robotaxi operations to Minneapolis, Tampa and New Orleans in the coming days, the ride-hailing service provider said on Thursday, as it accelerates the broad rollout of its services in the U.S. The company said it will begin operations in the new markets with human-driven vehicles, following a phased playbook …

Waymo to broaden US robotaxi footprint with moves into Minneapolis, Tampa, New Orleans Read More »

Starbucks must face shareholder lawsuit over surprise sales decline

By Jonathan Stempel (Reuters) -Starbucks must face a lawsuit claiming it defrauded shareholders by concealing declining sales in the United States and China, its largest markets, leading to a 16% drop in its stock price after the coffee chain revealed the unexpected weakness. In a decision late on Wednesday, U.S. District Judge John Chun in …

Starbucks must face shareholder lawsuit over surprise sales decline Read More »

Insurance IPOs hit 20-year high on Wall Street after tariff-driven chaos

By Arasu Kannagi Basil and Ateev Bhandari (Reuters) -Insurance companies’ first-time share sales on Wall Street hit a 20-year high this year as investors flocked to firms that were insulated from U.S. President Donald Trump’s trade war. Predictable cash flows and resilient business model gave private equity firms an opportunity to sell some portfolio companies …

Insurance IPOs hit 20-year high on Wall Street after tariff-driven chaos Read More »

Global tech shares surge as Nvidia’s AI boom powers market rally

By Rashika Singh and Rae Wee (Reuters) -Global technology shares rallied on Thursday after Nvidia’s blow-out quarterly results signaled that demand for artificial intelligence hardware remains strong even as concerns of the historic boom outpacing fundamentals linger. The chip bellwether’s stellar results tempered some concerns over a potential AI bubble, although questions about the payoff …

Global tech shares surge as Nvidia’s AI boom powers market rally Read More »

US consumers expected to use credit cards more for holiday shopping, survey says

By Tatiana Bautzer NEW YORK (Reuters) -U.S. consumers expect to rely more heavily on credit cards for shopping during the Thanksgiving holiday season, according to a survey by credit bureau TransUnion.  According to TransUnion’s U.S. Consumer Pulse study that surveyed 3,000 people in October, 42% of consumers intend to use credit cards to pay for …

US consumers expected to use credit cards more for holiday shopping, survey says Read More »

Bath & Body Works warns of holiday sales dip on weak discretionary spending

(Reuters) -Bath & Body Works forecast a surprise sales decline for the crucial holiday quarter on Thursday, warning of weak demand for its scented candles and fragrances among cash-strapped shoppers and sending its shares down nearly 14% in premarket trading. The retailer, whose shares have lost 46% of their value so far this year, also …

Bath & Body Works warns of holiday sales dip on weak discretionary spending Read More »

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

(Reuters) -Abbott said on Thursday it would buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first major push into cancer screening. The deal will add Exact Sciences’ flagship colorectal cancer test Cologuard and early-stage …

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences Read More »

Close Bitnami banner
Bitnami